- Investing Ideas
- /
- Swedish Biotech Stocks
Swedish Biotech Stocks
Results
49
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
49 companies
Swedish Orphan Biovitrum
Market Cap: SEK 115.0b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 333.80
7D
0.3%
1Y
3.9%
Camurus
Market Cap: SEK 36.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 611.00
7D
-0.8%
1Y
3.7%
BioArctic
Market Cap: SEK 27.4b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 309.60
7D
-0.4%
1Y
47.7%
Vitrolife
Market Cap: SEK 17.8b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 131.30
7D
-4.2%
1Y
-39.7%
Bonesupport Holding
Market Cap: SEK 12.0b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 182.70
7D
-2.8%
1Y
-54.2%
BioGaia
Market Cap: SEK 10.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 105.60
7D
-0.6%
1Y
-4.3%
MedCap
Market Cap: SEK 8.1b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 534.00
7D
-2.7%
1Y
-14.6%
Swedencare
Market Cap: SEK 6.1b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 38.10
7D
-0.8%
1Y
-16.6%
Flerie
Market Cap: SEK 2.9b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 37.30
7D
-0.4%
1Y
-21.1%
Saniona
Market Cap: SEK 2.9b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 20.90
7D
-1.4%
1Y
183.6%
Egetis Therapeutics
Market Cap: SEK 2.0b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.03
7D
-5.8%
1Y
-24.8%
Devyser Diagnostics
Market Cap: SEK 1.8b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 110.60
7D
-3.2%
1Y
-7.8%
BICO Group
Market Cap: SEK 1.4b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 19.55
7D
-7.2%
1Y
-38.1%
Oncopeptides
Market Cap: SEK 1.3b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 4.76
7D
-1.0%
1Y
208.0%
Orexo
Market Cap: SEK 1.2b
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 35.75
7D
18.8%
1Y
84.9%
Xspray Pharma
Market Cap: SEK 1.2b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 29.15
7D
-7.3%
1Y
-33.7%
Cantargia
Market Cap: SEK 1.0b
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 4.21
7D
0.6%
1Y
150.6%
FluoGuide
Market Cap: SEK 588.6m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 36.00
7D
5.0%
1Y
-28.0%
Moberg Pharma
Market Cap: SEK 470.0m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 10.00
7D
-2.6%
1Y
0.5%
Ascelia Pharma
Market Cap: SEK 396.5m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.13
7D
-2.8%
1Y
9.6%
Mendus
Market Cap: SEK 357.6m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 6.00
7D
7.1%
1Y
-30.2%
Xbrane Biopharma
Market Cap: SEK 215.1m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 10.44
7D
2.4%
1Y
-51.3%
Medivir
Market Cap: SEK 206.4m
A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Sweden, the Nordic region, rest of Europe, and internationally.
MVIR
SEK 0.46
7D
12.5%
1Y
-85.6%
Isofol Medical
Market Cap: SEK 205.5m
Operates as a clinical stage biotech company.
ISOFOL
SEK 0.73
7D
0.3%
1Y
-73.0%
SenzaGen
Market Cap: SEK 172.9m
Provides non-animal tests for assessing allergenicity.
SENZA
SEK 5.86
7D
-3.6%
1Y
-16.3%
IRLAB Therapeutics
Market Cap: SEK 172.4m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.03
7D
3.0%
1Y
-81.6%
Sprint Bioscience
Market Cap: SEK 158.8m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 1.51
7D
2.4%
1Y
-6.1%
Abera Bioscience
Market Cap: SEK 134.7m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 7.30
7D
7.4%
1Y
78.0%
Biovica International
Market Cap: SEK 129.6m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.44
7D
20.0%
1Y
-75.7%
Karolinska Development
Market Cap: SEK 115.2m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDEV
SEK 0.43
7D
-2.1%
1Y
-57.0%
Alzinova
Market Cap: SEK 86.8m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.83
7D
0.4%
1Y
-74.5%
IDL Diagnostics
Market Cap: SEK 85.0m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.37
7D
4.5%
1Y
-15.4%
PEPTONIC medical
Market Cap: SEK 92.1m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
PMED
SEK 0.06
7D
0%
1Y
-27.7%
Vivesto
Market Cap: SEK 66.2m
Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.12
7D
-8.9%
1Y
-54.0%
Nanologica
Market Cap: SEK 65.7m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
NICA
SEK 0.74
7D
-4.6%
1Y
-60.6%
AcouSort
Market Cap: SEK 61.4m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 2.90
7D
2.5%
1Y
-75.8%